Asian Journal of Research and Reports in Gastroenterology

Parotid Abscess in an Ulcerative Colitis Patient on Infliximab: A Case Report

Nacer Sara *

Hepato-Gastro-Enterology Department, UHC Ibn Rochd, Casablanca, Morocco.

Haddad Fouad

Hepato-Gastro-Enterology Department, UHC Ibn Rochd, Casablanca, Morocco.

El Rhaoussi Fatima-Zahra

Hepato-Gastro-Enterology Department, UHC Ibn Rochd, Casablanca, Morocco.

Tahiri Mohamed

Hepato-Gastro-Enterology Department, UHC Ibn Rochd, Casablanca, Morocco.

Hliwa Wafaa

Hepato-Gastro-Enterology Department, UHC Ibn Rochd, Casablanca, Morocco.

Bellabah Ahmed

Hepato-Gastro-Enterology Department, UHC Ibn Rochd, Casablanca, Morocco.

Badre Wafaa

Hepato-Gastro-Enterology Department, UHC Ibn Rochd, Casablanca, Morocco.

*Author to whom correspondence should be addressed.

---

Abstract

Anti–Tumor Necrosis Factor- alpha (anti–TNFα)) is a widely used immunosuppressive drug in inflammatory bowel disease (IBD). Parotid abscess results as a complication of the primary parotitis. It is an uncommon condition, that occurs in immunocompromised host. To our knowledge, it seems to be the first case described in the literature of an ulcerative colitis who developed a parotid abscess as an adverse effect to infliximab.

Keywords: Infliximab, Crohn’s disease, parotid, abscess, antibody

---

---